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1, I N I ' I ;G)DUCI ' I¢ )N  
Cholera toxitl (CT) c×crtcd a stimttlatory effect ou 
arachidonic acid (AA) metabolism as well as on adcnyl- 
ate cyclase [1-4]. The precise tn¢chalaism of CT activa- 
tion of phospholipase activity was not clear, although 
an initial study by Burch et al, [1] indicated that PLAz, 
rather than PI..C, may be iuvolved, 'I'hcir studies 
showed that CT and pertttssis toxin cau,,~cd the ac- 
cumuhttion of lysophosphatidylinositol and glycero- 
phosphoinositol in a routine macrophage/rnonocyte 
cell line, Further, minitxaal appearance of inositol phos- 
phates was observed. Only phosphatidyl inositol 4,5- 
bisphosphatc (PIP:) and not other phospholipids 
decreased in concentration i response  to these toxins. 
Indirect evidence favoring PLC activation by CT in- 
dicated that CT-induced [~I-I]AA release from murine 
macrophages was blocked by aspirin but not by dexa- 
methasone [5]. Whether hydrolysis of PIPz occurred by 
a one step (PLA,..) or a two step reaction (PLC and 
diglyceride lipase), ttle end result was AA accumulation 
in the cells. Since AA was a limited substrate, it was 
quickly converted to a variety of PGs by the cyclo- 
oxygenase pathway [6]. Therefore, we searched for 
points in the metabolic pathway whe:e the effects of CT 
might be interrupted by administration of a metabolic 
inhibitor. This report indicated that ehloroquine, a po- 
tent inhibitor of PLA2 and PLC [7,8], effectively in- 
hibited CT-induced AA release and PG synthesis in 
murine macrophages. 
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2, MATEI~,IAI.S AND METtlODS 
2. I, ~htcrol~h(tge t'ttltltr(:'s attt/ hlheii/i) *.
Motiola,vcr,,, of ~ InacrcH)hage/monocyt(~ c¢11 line (R:tw 26.1.7) 
{ATCC, i;toekville, MD) wilh [~ll lAA,labclcd l~hosl~holil~idx were 
establishe,,l as described it~ det~fil d~wl lerc  [t,SI, Ilricfly, I ITll of It 
labeled Itlal¢l'C,l~h:lge c ll suspcn~,iOll (4 :,¢ I O ~ cell,s) wus added to caeh 
well of 24-well tissue ,.'ulture plutcs (Falcon), All plates were inctlbatcd 
overniF, ht at 37°¢. ' ~'ith 5% CC).,. Ilcforc CT or chloroquille was add- 
ed, tile mOllola!,'er.', were washed 3 x with PIIS alld 1 11'tl aliqtlots of 
fresh) culltlr¢ Illediunl ,,,,'ere udded, 
2.2. Administratio/I of  drugs at~d C7' to tttacr~phage c ll c'tdtltct,s 
Labeled nl~,lcroph:lges were tre:llcd with ,~hl0roquine phosph,:'de 
(Sigma Chemical C'o,, St, l,ouls, MO) lit designated colteezttratiolls 
for 1 h) before CT ( I~)  ng/n'd) w;is added to the c,)ilturc medium, then, 
they were ineul~ated f'or .'lllolher 2 h whh or without CT. In the kii,)etie 
study, ehlorotlUhle (500 #g/i,)ll) was udded at vllrious tilne intervals 
rehitive to the time of (2'I' addition, Assuy for [JI-IiAA metaholite 
release was Derformed b~,' sampling tile culture superualunts as 
described by Reilrneyer al'id Peterson [2], 
2,3, i lPLC cztlalysis of  prostaglandins 
Labeled monolayet's (2 × 10 ~ cells), growing in 75 cm-" flasks, were 
washed (3 × ) ~vitlt PtIS, Fresh 12)ulbcceo's naeditmn (10 ml) was added 
to all f lasks, which) were ra,~domly selc¢tcd to serve as cell controls, 
CT controls (2#g/ml), or drug + CT treatme,u groups. After addi- 
tion of drug and/or  C'I', flasks were incubated for 4 h at 37°C with 
50;o COz, at which) !aoint the media were removed and analyze0 for 
PGs, Extraction and HPLC separation of  prostaglandins were per- 
for,ned as described by Peterson et al. [6], 
2.4, Cyclic AMP extraction attd assay 
Two ml aliquots of  a macrophage cell suspension (4 x 10 "~ cells/ml) 
were incubated (37"C and 5°70 CO2) overnight in tissue culture dishes 
(Falcon), Culture supernatants were aspirated and replaced with 2 ml 
of fresh medium. CT (100 ng/ml) with or without chloroquine (10 or 
100,ug/ml) was added, aud the cultures were incubated for 4 h. Then, 
cAMP was extracted from the macrophae.e cell monolayers and 
assayed by a radioimmunoassay as described by the manufacturer  
(Advanced Magnetics Inc., Cambridge, MA). 
2.5. Statistics 
Data were analyzed by a one.way ANOVA followed by the Tukey 
test. The dose response and kinetic experiments reflect the means of 
quadruplicate determinations :t:: 1 SD. The cAMP data depict pooled 
values of  two experiments each performed in quadruplicate. All ex- 
periments were performed at least twice with comparable results. 
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3. RESULTS 
3.1. Effect of chloroquine on ["It/AA release 
Fig. 1 illustrates the inhibitory effects of ehloroquine 
on CT-indueed ['~H]AA release in murine 
macrophages/monocytes. Addition of chtoroquine to 
the culture medium 1 h before CT (100 ng/ml) in con- 
ccntrations of 50/,g/ml and above blocked ['~H]AA 
release completely (P< 0.05). Addition of chloroquine 
in concentrations of 10/,g/ml and below was not cffcc- 
tire in altering the stimulatory effects of CT on AA 
metabolism (P>~ 0.05). 
3.2. Kinetics of chloroquine administration 
Fig. 2 indicated that the stimulatory effects of CT on 
AA metabolism occurred very early. Addition of 
chloroquine (500/~g/ml) before, or as late as 30 rain 
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Fig. 2. Effect of time of chloroquine addition on CT-induced [~H]AA 
release. Chloroquine UO0/~g/ml) was added at various t ime intervals 
relative to the time of CT (100 ng/ml)  application. Tile arrow in- 
dicates the time at which CT was added. Incubation time with CT was 
3 h for every sample. All data points are means of qt~adtuplieate 
determinations on replicate monolayers, and the vertical bars and 
dash:d horizontal ines denote one standard deviation. The CT and 
Cell Controls were derived as indicated in Fig. 1. 
after CT (100 ng/ml) application, resulted in total in- 
hibition of CT-induced ['~H]AA release (P~O.O5). Par- 
tial inhibition was noted when the drug was added 1-2 
h after the toxin. By 3 h, no inhibitory effects of the 
drug were detected (P>0.05). 
3.3. Chloroquine inhibition of PG ,9,ntlw.~'is 
Inhibition of [~H]AA release from CT-treatcd cells 
constituted a metabolic blockade for subsequent syn. 
thesis of a variety of PGs. Fig. 3 illustrated the relative 
effectiveness of chloroquine in preventing CT-induced 
synthesis of PGs. The uppermost curve (CT treatment), 
when compared to the lowermost curve (cell control), 
depicted increased synthesis of PGI2, T×B:, PGF2ca,, 
PGE2, and PGE~. PGA.,. and PGB., are nonenzymatic 
degradation products of the relatively labile PGE2. PG 
synthesis in cells exposed to CT in the presence of 
chloroquine (~0/(g/ml) appeared similar to that of the 
cell control. When only 10 ~g/ml of chloroquine was 
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Fig, 4, Effect of chloroquine (CQ) on cellular cAMP levels, Chloro- 
quine (10/~g/ml and 100#g/ml) decreased basal levels of cAMP in the 
macrophages/monocytes;  it also had a minimal inhibitory effect on 
cholera toxin (CT)-induced increased cAMP levels P.~O,05). 
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3.4, EJfccl o.f chh,'oquim' oJa c.'l A!I ~ levels' 
Fig..1 stmlmari/cd the el'feet,, of t,,l' on ilm'ac¢lhthtr 
Icvcl~ of cAMP in marline iI'l~tcroph;t.ges ill the presmlcc 
:.U'ld al}S¢llk:e Of ¢hlt}roqllhlc. ('lllor¢ltltlillc lowered bas;d 
levels ot' cAM P in the IIt;tct'~l~llagcs/t~¢,llt~cyl¢'~, 
aithtm.t,,h these ch;.ttlb,¢s svCre IiOt cottsidcretd signil'icant 
{/'~;', 0,05), (?hloroqttin¢ had ininimal inhibitt~ry effects 
on CF-induced cAMP levels, although the decrease was 
constricted statistically significant by the Tttkey test 
{1-~;0.05) at either dose. The CT.induccd cAMP a¢- 
ctunul;ttion ill chloroqtfit~e.treated ccll,~ was significant. 
ly elevated above the respective controls {[:L.:~O.(}I). 
4. I)ISCUSSiON 
Chloroqnine proved tt, be u very el'fectivc inhibitor of 
C'['-imhtccd ['~tl]AA release and subsequent I}G syn- 
thesis hi nlurine nmcrophagcs/monocytes. The dose of 
chloroquine ffective in inhibiting [aFIIAA release was 
50/+g/ml (Fig. 1), and Jt was important that the drug be 
added to the culture mediun~ within 30 ntin of the toxin 
(Fig. 2). Sttch kinetic characteristics indicated that CT 
evoked an early stimulatory effect on arachidonic acid 
metabolism suppporting the earlier observation of 
Reitmeyer and Pctcrson [2] that ['~H]AA release began 
within 5 rain of exposure to CT. This inhibition of CT- 
induced AA release also was reflected in the PG syn- 
thesis profile (Fig. 3). Normally, CT caused the syn. 
thesis of numerous POs including PGb, TxBz, PGFztv, 
PGEa, PGE~, PGA~, and PGB2. lntracellular levels of 
cAMP were increased in response to CT, while chloro- 
quine reduced cAMP minimally in both CT and control 
groups (Fig. 4). These observations suggested that CT- 
induced synthesis of cAMP occurred independent of 
the to×in's effect on AA metabolism leading to PG syn- 
thesis. Chloroquine blocked CT action by uncoupling 
cAMP-mediated events required for AA release [6]. 
Without AA release occurring in CT-treated cells, PG 
synthesis also was not possible. 
Chloroquine previously has been shown to inhibit 
secretion of water and electrolytes in rat intestinal per- 
fusion loops in vivo anti CI- transport across isolated 
rabbit macosa in vitro [10]. These observations clearly 
documented the protective effect of chloroquine against 
CT-induced alterations in vascular permeability; 
however, the molecular basis for the drug's activity was 
unknown. We attributed the antisecretory effect of 
ehloroquine to its capacity to inhibit phospho l ipase  ac- 
t ivity, which in turn, prevented CT-induced AA release. 
A related rug, chlorpromazine, that blocked PLC and 
PLAz activity [8,9] a lso has been demonstrated to 
possess antisecretory activity; however, we observed 
less inhibition of CT-induced AA release by the latter 
drug (data not  shown) .  Interestingly, drugs that block-  
ed cyclo-oxygenase activity (e.g. indomethac in  and 
aspirin) aim pos,+cssed :llllis¢cretol'y activitie,~ [I 1~14t. 
Wc al~t~ Ila,'e ub~ervcd that aspirin inhibited [IHIAA 
I'eI¢IP,¢ fl'Olll illii¢l'ol~h~.|ge'~tlllOllOCytes [5]; howeVel', 
hi.~h th~cs ( i  luglml) of iml~m~¢tha¢in failed to block 
[~II]AA release (tlat;~ not sho~,vtt)¢v¢11 though lower 
tlt~s¢,~ (10 ig,,./ml)blocked C'l'-indu¢cd P(i synthesi.s [51, 
This information, cm',bined with that of other studies 
correlating P() synthesis with CT-inthtced secretion 
[1 5], inlplicated AA inetalmlites in the mechanism of 
action of (~['. 
Chlort~quiuc has been tested in cholera patients 
without diminishing the severity or duratiml of the 
disease [16]. CT effects on AA metabolism occurred 
c;at'ly, at~d us shown in this study, chloroquille had to be 
added within 3(1 thin ol tile toxin to elicit rely inhibitory 
effect. Thus, it is not surprising that past clinical trials 
with this drug were less th:m encouraging. Based upon 
the kinetic data l~rcsentcd in this report, it ,night bc an- 
ticipated that ¢holern patients would not respond to 
drug treatment once Syml~tOms of fluid loss began. If 
this drug were to have clinical ~lpplication, it would 
have to be adnlinistered very early. It is unknown 
whether chloroquine could be used prophylactically to
prevent symptoms of cholera in the same manner that 
the drug is used to prevent malaria, Nevertheless, the 
drug appears useful in defining the molecular 
meclmnism of cholera to×in. 
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